Introduction: new directions in anticancer chemotherapy
Khayat, D.
Seminars in Oncology 24(4 Suppl. 11): S11
1997
ISSN/ISBN: 0093-7754 PMID: 9314291 Document Number: 474782
Document emailed within 1 workday
Related Documents
Thase, M.E. 2007: Introduction: new directions in the treatment of atypical depression Journal of Clinical Psychiatry 68 Suppl. 3: 4-9Kaufmann, S.H.; Hancock, R. 1995: Topoisomerase Ii as a target for anticancer chemotherapy Acta Biochimica Polonica 42(4): 381-393
Nishiyama, M. 2008: Genomic markers and anticancer chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(2): 194-199
Fière, D. 1981: Preventive and complementary anticancer chemotherapy La Revue du Praticien 31(43): 3021
Andrysek, O. 1983: Our initial experience with mitomycin C in anticancer chemotherapy Casopis Lekaru Ceskych 122(26): 813-818
Tateda, K. 2012: Antibiotic-resistant bacteria and new directions of antimicrobial chemotherapy Rinsho Byori. Japanese Journal of Clinical Pathology 60(5): 443-448
Matsuoka, T.; Yoshimura, T.; Asano, H.; Adachi, S.; Okada, K.; Yasuda, T. 2013: Induction of allergic reactions by anticancer drugs in outpatient chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(2): 209-214
Ohkoshi, M. 1995: Protease inhibitors as anticancer chemotherapy--experimental and clinical studies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 417-430
Ozols, R.F.; Vermorken, J.B. 1997: Chemotherapy of advanced ovarian cancer: current status and future directions Seminars in Oncology 24(1 Suppl 2: S2
Kitamura, Y.; Suzuki, H.; Ankou, H. 1989: Intraarterial chemotherapy of experimentally metastasized liver carcinoma with anticancer emulsion containing surface-active agent Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(11): 3615-3620
Fujita, F.; Fujita, M.; Inaba, H.; Sugimoto, T.; Okuyama, Y.; Taguchi, T. 1991: Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(13): 2263-2270
Israel, L.; Breau, J.L.; Morère, J.F.; Aguilera, J.; Kohn, M. 1986: Induction of objective responses by an anticancer chemotherapy based on the prolonged combination of bleomycin and cisplatin. 1062 cases Presse Medicale 15(25): 1183-1186
Israël, L.; Breau, J.L.; Morere, J.F.; Lepage, E.; Aguilera, J. 1985: Inhibition of DNA repair, major objective of anticancer chemotherapy. Apropos of 680 cases with continuous platin bleomycin combination Annales de Medecine Interne 136(1): 17-20
Takahashi, T.; Mizuno, M.; Fujita, Y.; Ueda, S.; Nishioka, B. 1973: Increased concentration of anticancer agents in regional lymph nodes by fat emulsions, with special reference to chemotherapy of metastasis Gan 64(4): 345-350
Kühn, H.; Jähnichen, T. 1970: Pneumonia before and after introduction of chemotherapy Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 113(2): 198-207
Sighart, H. 1983: Treatment of tuberculosis before the introduction of chemotherapy Zeitschrift für Erkrankungen der Atmungsorgane 161(1): 56-60
Chandra, J.; Naithani, R.; Singh, V.; Saxena, Y.K.; Sharma, M.; Pemde, H. 2008: Developing anticancer chemotherapy services in a developing country: Hodgkin lymphoma experience Pediatric Blood and Cancer 51(4): 485-488
Hemmer, J.; Kreidler, J.; Kraft, K.; Schön, E. 1994: Monitoring of anticancer drug effects in vivo by serial DNA flow cytometry of oral carcinomas treated by intra-arterial 5-fluorouracil/cisplatin induction chemotherapy Anticancer Research 14(5b): 2077-2083
Scher, H.I.; Splinter, T.A. 1990: Chemotherapy for invasive bladder cancer: introduction Seminars in Oncology 17(5): 515-516
Coutin, R. 1998: Introduction of pests and introduction or risk of introduction of injuriousness organisms: information published on these subjects in Phytoma-LdV Phytoma (Paris) 506: 24-26